Delaying Denosumab Dose Boosts Risk for Vertebral Fractures Delaying Denosumab Dose Boosts Risk for Vertebral Fractures

Patients who delayed the recommended 6-month dose by more than 16 weeks were nearly four times more likely to suffer vertebral fractures, according to a new the study.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news